In vitro characterization of tooth-derived and dentin-derived graft particles: Comparative analysis of particle size, mineral composition, and cytotoxicity
Abstract
Background/purpose: Characteristics of grafting material influence its osteoconductive and osteoinductive properties. This study aimed to compare tooth-derived particles (TDPs) with dentin-derived particles (DDPs) with respect to particle size, demineralization behavior, elemental composition, and cytotoxicity.
Materials and methods: TDP materials and DDP materials were cleaned, air-dried, ground using a Smart Dentin Grinder (KometaBio, Bergen, NJ, United States), and sorted by particle size. Both materials were demineralized with 10 % ethylenediaminetetraacetic acid (EDTA) at various time points and analyzed by scanning electron microscopy and energy-dispersive X-ray spectroscopy to determine the structural changes and the time required to reach 30 % residual Ca. Samples that achieved this level were subsequently evaluated for cytotoxicity according to ISO 10993-12:2021.
Results: Particle size distribution was significantly different between TDPs and DDPs. The proportion of particles suitable for grafting was higher in DDPs (69.12 %) than in TDPs (55.98 %). Although the percentages of Ca and P during demineralization were slightly higher in TDPs than in DDPs, the differences were not significant. Both Ca and P contents, as well as the Ca/P ratio, decreased significantly with increasing demineralization time. Samples from both groups, adjusted to approximately 30 % residual Ca, were non-cytotoxic and met the ISO safety criteria for biological experimentation.
Conclusion:…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.